自体造血干细胞移植联合利妥昔单抗治疗B细胞非霍奇金淋巴瘤
出处
《中国医师进修杂志（内科版）》
2006年第9期65-67,共3页
Chinese Journal of Postgraduates of Medicine
参考文献21
-
1Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high - dose chemotherapy and autologous stem cell support. New Engl J Med,2004,350( 13 ) : 1287 -1295. 被引量：1
-
2Schouten HC, Kvaloy S, Sydes M, et al. The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low grade non - Hodgkin's lymphoma(NHL). Ann Oncol,2000,11(Suppl 1) :s91 -s94. 被引量：1
-
3Mangel J, Leitch HA, Connors JM, et al. Intensive chemotherapy and autologous stem - cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantlecell lymphoma: a matched pair analysis. Ann Oncol, 2004, 15(2) :283 - 290. 被引量：1
-
4van Heeckeren WJ, Vollweiler J, Fu P, et al. Randomised comparison of two B - cell purging protocols for patients with B - cell non -Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with clinic MACS CD34 cell enrichment device. Br J Haematol,2006, 132(1 ) :42 -55. 被引量：1
-
5Kuittinen T, Wiklund T, Remes K, et al. Outcome of progressive disease after autologous stem cell transplantation in patients with non -Hodgkin lymphoma: a nation - wide survey. Eur J Haematol, 2005,75(3) :199 -205. 被引量：1
-
6Mahe B, Milpied N, Mellerin MP, et al. PCR detection of residual Bcl - 2/lgH - positive cells 'after high - dose therapy with autologous stem cell transplantation is a prognostic factor for event - free survival in patients with low - grade follicular non - Hodgkin lymphoma. Bone Marrow Transplant, 2003,31 (6) : 467 -473. 被引量：1
-
7Naparstek E. The role of the anti - CD20 antibody rituximab in hematopoietic stem cell transplantation for non - Hodgkin lymphoma. Curr Hematol Rep,2005,4 ( 4 ) :276 - 283. 被引量：1
-
8Gribben JG, Freedman AS, Neuberg D, et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B - cell lymphoma. N Engl J Med, 1991,325 (22) : 1525 -1533. 被引量：1
-
9Paulus U, Dreger P, Viehmann K, et al. Purging peripheral blood progenytor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34^+ selection systems. Stem Cell, 1997,15 (4) :297 - 304. 被引量：1
-
10Bensinger WI. Should we purge? Bone Marrow Transplant, 1998,21 (2): 113-115. 被引量：1
-
1李桥川,孙洪波,李云涛,邱录贵.CD_(20)单克隆抗体联合自体干细胞移植治疗非霍奇金淋巴瘤[J].国外医学（输血及血液学分册）,2004,27(4):342-345. 被引量：1
-
2刘维.来那度胺联合利妥昔单抗作为套细胞淋巴瘤初始治疗方案[J].临床药物治疗杂志,2016,14(2):89-89. 被引量：2
-
3王开叶.不同剂量米非司酮治疗子宫肌瘤效果比较[J].中外女性健康研究,2016(10):13-13. 被引量：5
-
4龚晓清,何娜.浅议晚期食管癌近距离照射临床护理[J].中国中医药咨讯,2011,3(18):349-349.
-
5秦燕,石远凯,何小慧,韩晓红,周生余,刘鹏,杨建良,杨晟,张长弓,董梅,周立强,王金万,冯奉仪,孙燕.单纯CHOP样方案与CHOP样方案联合造血干细胞移植巩固治疗淋巴母细胞淋巴瘤的疗效分析[J].中华肿瘤杂志,2009,31(6):469-473. 被引量：9
-
6石远凯,史幼梧.自体造血干细胞移植治疗恶性淋巴瘤的临床研究进展[J].中国肿瘤临床,2015,42(1):1-7. 被引量：6
-
7李鹏,周鹏云,吴三妮.腹腔镜联合高强度聚焦超声治疗子宫腺肌病合并浆膜下子宫肌瘤[J].腹腔镜外科杂志,2014,19(8):629-629. 被引量：3
-
8曹彩红,赵曙,张清媛.B细胞淋巴瘤信号通路及靶向治疗的最新进展[J].临床血液学杂志,2015,28(1):81-83. 被引量：4
-
9史幼梧,石远凯,秦燕,刘鹏,桂琳,周生余,杨建良,何小慧,张长弓,杨晟,韩晓红,孙燕.单纯Hyper-CVAD方案或联合自体造血干细胞移植一线治疗淋巴母细胞淋巴瘤的疗效分析[J].中国肿瘤临床,2015,42(1):13-18. 被引量：3
-
10徐丽,万滢,张良满.1例自体造血干细胞移植联合抗CD20单抗治疗弥漫大B细胞非霍奇金淋巴瘤患者的护理[J].中国实用护理杂志（下旬版）,2008,24(1):48-49.
